{"id":"https://openalex.org/W2236481664","doi":"https://doi.org/10.1016/j.dsx.2015.10.001","title":"A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome","display_name":"A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome","alternate_titles":[],"publication_year":2015,"publication_date":"2015-11-13","ids":{"openalex":"https://openalex.org/W2236481664","doi":"https://doi.org/10.1016/j.dsx.2015.10.001","mag":"2236481664","pmid":"https://pubmed.ncbi.nlm.nih.gov/26703220"},"language":"en","primary_location":{"id":"doi:10.1016/j.dsx.2015.10.001","doi":"https://doi.org/10.1016/j.dsx.2015.10.001","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.dsx.2015.10.001","pdf_url":null,"source":{"id":"https://openalex.org/S125677163","display_name":"Diabetes & Metabolic Syndrome Clinical Research & Reviews","issn_l":"1871-4021","issn":["1871-4021","1878-0334"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2236481664"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/journal_contribution/A_comparative_study_to_illustrate_the_benefits_of_using_ethinyl_estradiol-cyproterone_acetate_over_metformin_in_patients_with_polycystic_ovarian_syndrome/22932401","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016536145","display_name":"Noorhan S. Mhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47229656","display_name":"University of Kufa","ror":"https://ror.org/02dwrdh81","country_code":"IQ","type":"education","lineage":["https://openalex.org/I47229656"]}],"countries":["IQ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Noorhan S. Mhao","raw_affiliation_strings":["Department of Medicine, College of Medicine, Kufa University, Najaf, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, College of Medicine, Kufa University, Najaf, Iraq","institution_ids":["https://openalex.org/I47229656"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087619515","display_name":"Ahmed S. Al-Hilli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I47229656","display_name":"University of Kufa","ror":"https://ror.org/02dwrdh81","country_code":"IQ","type":"education","lineage":["https://openalex.org/I47229656"]}],"countries":["IQ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ahmed S.A. Al-Hilli","raw_affiliation_strings":["Department of Medicine, College of Medicine, Kufa University, Najaf, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, College of Medicine, Kufa University, Najaf, Iraq","institution_ids":["https://openalex.org/I47229656"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062531798","display_name":"Najah Raiesh Hadi","orcid":"https://orcid.org/0000-0002-8415-5311","observed_orcids":["https://orcid.org/0000-0002-8415-5311"]},"institutions":[{"id":"https://openalex.org/I47229656","display_name":"University of Kufa","ror":"https://ror.org/02dwrdh81","country_code":"IQ","type":"education","lineage":["https://openalex.org/I47229656"]}],"countries":["IQ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Najah R. Hadi","raw_affiliation_strings":["Department of Pharmacology, College of Medicine, Kufa University, Najaf, Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, College of Medicine, Kufa University, Najaf, Iraq","institution_ids":["https://openalex.org/I47229656"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017196944","display_name":"Dina A. Jamil","orcid":"https://orcid.org/0000-0002-0537-375X","observed_orcids":["https://orcid.org/0000-0002-0537-375X"]},"institutions":[{"id":"https://openalex.org/I129801699","display_name":"University of Tasmania","ror":"https://ror.org/01nfmeh72","country_code":"AU","type":"education","lineage":["https://openalex.org/I129801699"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dina A. Jamil","raw_affiliation_strings":["School of Medicine, University of Tasmania, TAS, 7001, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, University of Tasmania, TAS, 7001, Australia","institution_ids":["https://openalex.org/I129801699"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078748374","display_name":"Hayder A. Al-Aubaidy","orcid":"https://orcid.org/0000-0001-9564-0120","observed_orcids":["https://orcid.org/0000-0001-9564-0120"]},"institutions":[{"id":"https://openalex.org/I129801699","display_name":"University of Tasmania","ror":"https://ror.org/01nfmeh72","country_code":"AU","type":"education","lineage":["https://openalex.org/I129801699"]}],"countries":["AU"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Hayder A. Al-Aubaidy","raw_affiliation_strings":["School of Medicine, University of Tasmania, TAS, 7001, Australia. Electronic address: h.alaubaidy@utas.edu.au","School of Medicine, University of Tasmania, TAS, 7001, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Medicine, University of Tasmania, TAS, 7001, Australia. Electronic address: h.alaubaidy@utas.edu.au","institution_ids":["https://openalex.org/I129801699"]},{"raw_affiliation_string":"School of Medicine, University of Tasmania, TAS, 7001, Australia","institution_ids":["https://openalex.org/I129801699"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5078748374"],"corresponding_institution_ids":["https://openalex.org/I129801699"],"apc_list":{"value":4450,"currency":"USD","value_usd":4450},"apc_paid":null,"fwci":2.0764,"has_fulltext":false,"cited_by_count":27,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.83810745,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"10","issue":"1","first_page":"S95","last_page":"S98"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polycystic-ovary-syndrome","display_name":"polycystic ovary syndrome","score":0.9919999837875366},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9629999995231628},{"id":"https://openalex.org/keywords/serum-lipids","display_name":"serum lipids","score":0.7329999804496765},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.7739999890327454},{"id":"https://openalex.org/keywords/hdl-cholesterol","display_name":"HDL cholesterol","score":0.8960000276565552},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.9129999876022339},{"id":"https://openalex.org/keywords/vldl-cholesterol","display_name":"VLDL cholesterol","score":0.902999997138977},{"id":"https://openalex.org/keywords/testosterone","display_name":"testosterone","score":0.703000009059906},{"id":"https://openalex.org/keywords/glucose-tolerance","display_name":"glucose tolerance","score":0.9110000133514404},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.8479999899864197},{"id":"https://openalex.org/keywords/menstrual-cycle-regulation","display_name":"menstrual cycle regulation","score":0.9279999732971191},{"id":"https://openalex.org/keywords/hirsutism","display_name":"hirsutism","score":0.9520000219345093},{"id":"https://openalex.org/keywords/acne-vulgaris","display_name":"acne","score":0.953000009059906},{"id":"https://openalex.org/keywords/hyperandrogenism","display_name":"hyperandrogenism","score":0.9449999928474426}],"concepts":[{"id":"https://openalex.org/C2777155358","wikidata":"https://www.wikidata.org/wiki/Q426185","display_name":"Cyproterone acetate","level":4,"score":0.9434467554092407},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7725386619567871},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.7159007787704468},{"id":"https://openalex.org/C2776371013","wikidata":"https://www.wikidata.org/wiki/Q1620594","display_name":"hirsutism","level":5,"score":0.6871943473815918},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6841504573822021},{"id":"https://openalex.org/C2776306840","wikidata":"https://www.wikidata.org/wiki/Q7381206","display_name":"Cyproterone","level":5,"score":0.6819636821746826},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6456107497215271},{"id":"https://openalex.org/C3018442814","wikidata":"https://www.wikidata.org/wiki/Q500816","display_name":"Polycystic ovary","level":4,"score":0.5831412076950073},{"id":"https://openalex.org/C2777956591","wikidata":"https://www.wikidata.org/wiki/Q415563","display_name":"Ethinylestradiol","level":4,"score":0.467288076877594},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.45306214690208435},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.31730541586875916},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.29995298385620117},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.26379644870758057},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.15997859835624695},{"id":"https://openalex.org/C2777911890","wikidata":"https://www.wikidata.org/wiki/Q62614","display_name":"Androgen","level":3,"score":0.14899402856826782},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.14266642928123474},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C2986817661","wikidata":"https://www.wikidata.org/wiki/Q185698","display_name":"Research methodology","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000726","descriptor_name":"Androgen Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004997","descriptor_name":"Ethinyl Estradiol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008074","descriptor_name":"Lipoproteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011085","descriptor_name":"Polycystic Ovary Syndrome","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011085","descriptor_name":"Polycystic Ovary Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017373","descriptor_name":"Cyproterone Acetate","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.dsx.2015.10.001","doi":"https://doi.org/10.1016/j.dsx.2015.10.001","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.dsx.2015.10.001","pdf_url":null,"source":{"id":"https://openalex.org/S125677163","display_name":"Diabetes & Metabolic Syndrome Clinical Research & Reviews","issn_l":"1871-4021","issn":["1871-4021","1878-0334"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes &amp; Metabolic Syndrome: Clinical Research &amp; Reviews","raw_type":"journal-article"},{"id":"pmid:26703220","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26703220","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes & metabolic syndrome","raw_type":"Comparative Study"},{"id":"pmh:oai:ecite.utas.edu.au:105757","doi":null,"is_oa":false,"landing_page_url":"http://ecite.utas.edu.au/105757","pdf_url":null,"source":{"id":"https://openalex.org/S4406922975","display_name":"UTAS Research Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I129801699","host_organization_name":"University of Tasmania","host_organization_lineage":["https://openalex.org/I129801699"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Refereed Article"},{"id":"pmh:oai:figshare.com:article/22932401","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/A_comparative_study_to_illustrate_the_benefits_of_using_ethinyl_estradiol-cyproterone_acetate_over_metformin_in_patients_with_polycystic_ovarian_syndrome/22932401","pdf_url":null,"source":{"id":"https://openalex.org/S4406922975","display_name":"UTAS Research Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I129801699","host_organization_name":"University of Tasmania","host_organization_lineage":["https://openalex.org/I129801699"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/22932401","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/A_comparative_study_to_illustrate_the_benefits_of_using_ethinyl_estradiol-cyproterone_acetate_over_metformin_in_patients_with_polycystic_ovarian_syndrome/22932401","pdf_url":null,"source":{"id":"https://openalex.org/S4406922975","display_name":"UTAS Research Repository","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I129801699","host_organization_name":"University of Tasmania","host_organization_lineage":["https://openalex.org/I129801699"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1974799218","https://openalex.org/W1986902166","https://openalex.org/W2000904766","https://openalex.org/W2021450389","https://openalex.org/W2044970382","https://openalex.org/W2067082722","https://openalex.org/W2068815843","https://openalex.org/W2091687656","https://openalex.org/W2106378688","https://openalex.org/W2114157711","https://openalex.org/W2121670837","https://openalex.org/W2164302428","https://openalex.org/W2167875013","https://openalex.org/W2168941094"],"related_works":["https://openalex.org/W2347858420","https://openalex.org/W2370721090","https://openalex.org/W1995186041","https://openalex.org/W2030338684","https://openalex.org/W2968445389","https://openalex.org/W2114157711","https://openalex.org/W2000904766","https://openalex.org/W2394219939","https://openalex.org/W3029924347","https://openalex.org/W2020912017"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2236481664","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
